Regeneron to participate in guggenheim biopharma strategy series

Tarrytown, n.y., june 22, 2021 /prnewswire/ -- regeneron pharmaceuticals, inc. (nasdaq: regn) is scheduled to participate in a virtual fireside chat at the guggenheim biopharma strategy series – biopharma's next decade: views from the top on global strategy and innovation – at 10:00 a.m.

REGN Ratings Summary

REGN Quant Ranking